Chyron Acquires Axis Graphics And Launches Online Division

PITTSBURGH and GREENWICH, Conn., Dec. 4 /PRNewswire-FirstCall/ -- Oracle Healthcare Acquisition Corp. ("Oracle") (OTCBulletinBoard: OHAQ) (OTCBulletinBoard: OHAQW) (OTCBulletinBoard: OHAQU) , a publicly-traded special purpose acquisition company, announced today that it has entered into a definitive merger agreement providing for the acquisition of privately-owned Precision Therapeutics, Inc. ("PTI"), a life sciences company developing and commercializing tests intended to assist physicians in individualizing cancer therapy in an effort to improve treatment outcomes. Under the agreement, subject to the satisfaction of customary closing conditions, Pittsburgh-based PTI would be the surviving corporation in a merger with a subsidiary of Oracle. PTI would retain the Precision Therapeutics, Inc. read more